Navigation Links
Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT
Date:9/24/2007

EAST SETAUKET, N.Y., Sept. 24 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc. (OTC Bulletin Board: LIXT) today announced the trading of its common shares on the Over-The-Counter Bulletin Board under the Symbol LIXT.

Commenting on this important milestone, President and CEO John S. Kovach, M.D. stated, "We believe that being a publicly traded company will enable us to pursue funding opportunities that were not available to us as a private company. Having access to the capital markets is important at this stage of Lixte's development. Over the coming months our strategy is to continue with our research under a Cooperative Research and Development Agreement (CRADA) with the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH), while at the same time exploring other cancer research opportunities that Lixte is developing independently."

About Lixte Biotechnology Holdings, Inc.:

Lixte Biotechnology Holdings, Inc. (Lixte) is a cancer therapeutics and diagnostics company. Founded as a biomarker-diagnostics company in 2005, the company develops new chemotherapy drugs targeting molecular abnormalities of common human cancers. Over the past year, based on the discovery of a new biomarker for brain cancers by collaborators at NIH, the company is developing new drugs for the treatment of glioblastoma multiforme (GBM), the most common and most aggressive type of primary brain cancer in adults and, to a much lesser extent, in children.

GBM occurs annually in 20,000 to 25,000 adults in the United States and in a comparable number of individuals in Europe. At present, there is no curative treatment known for this disease. Standard treatment involves surgery, radiation and the use of one or more chemotherapeutic agents at the time of initial treatment. At relapse, which occurs in essentially all patients, the present standard treatment is a drug, Temozolomide, that is associated with a modest increase
'/>"/>

SOURCE Lixte Biotechnology Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Olympics of biotechnology has international flavor
2. Making Wisconsin the biotechnology leader
3. Let the olympics of biotechnology in the Midwest begin!
4. The mushrooming of biotechnology in the U.S.
5. 42 days until the 2006 Olympics of Biotechnology in Chicago
6. Third coast of biotechnology makes strong showing at VC conference
7. State wants to encourage industrial biotechnology
8. The Scientist magazine names Madison "hotspot" for biotechnology
9. First graduates boon to Wisconsin biotechnology
10. Americas Third Coast nurtures biotechnology
11. Florida: Investing Heavily in Biotechnology - Governor uses state funds to attract large biotech companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... and SHENZHEN, China , ... Co., LTD, (BGI Tech), a subsidiary of BGI, ... global launch of a new human whole exome ... This newly offered service includes in-depth bioinformatics analysis ... prices until December 31, 2014. ...
(Date:7/22/2014)... 22, 2014 Quorum Review IRB, the industry ... large clinical trials called Quick Step™ . The offering ... address the research industry’s need for seamless study start-up with ... available for studies planning 50 or more North American investigator ... North American site count of 80 or more. Qualifying studies ...
(Date:7/22/2014)... The next session of Clinovo’s TechTrainings ... of the increasingly popular ‘Base SAS’ and ‘CDISC Standards: ... of technical hands-on classes for entry-level to experienced clinical ... step in their professional careers. , The 9-week ... Senior Statistician at Genentech and former Senior Statistician at ...
(Date:7/21/2014)... A chemist in Syracuse University,s College of Arts ... study the synthesis of stainless nanoparticles. , Mathew ... awarded a three-year, $360,000 grant from the National ... work with metal stainless alloy nanostructures, the results ... and rechargeable lithium-ion batteries. , Maye,s ...
Breaking Biology Technology:BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 3Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 2Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 3Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 2Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 3Syracuse University chemist to use NSF grant to study materials chemistry, nanoscience 2
... April 8, 2008 BioMarin,Pharmaceutical Inc. (Nasdaq and ... Officer of BioMarin, will host a,conference call and ... ET (23:00,CET) to discuss first quarter 2008 financial ... 866.713.8310 International Dial-in Number: 617.597.5308 ...
... TAMPA, Fla., April 8, 2008 Sirion ... announced,today the presentation of data from two ... emulsion) 0.05%, a topical steroid in,the treatment ... given,in a presentation by Michael Korenfeld, MD ...
... The PerOs team is proud to announce,the USDA/CVB ... production,of bacterins as well as an autogenous bacterin ... "The approval of our manufacturing facility and ... marks a significant milestone for,our Company, and we ...
Cached Biology Technology:BioMarin to Host First Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, April 29 at 5:00 p.m. ET (23:00 CET) 2Sirion Therapeutics Highlights Pivotal Trial Results of Durezol(TM) at the American Society of Cataract and Refractive Surgery Annual Symposium 2Sirion Therapeutics Highlights Pivotal Trial Results of Durezol(TM) at the American Society of Cataract and Refractive Surgery Annual Symposium 3PerOs obtains USDA Establishment and Product Licenses for it's oral vaccine formulations 2
(Date:7/22/2014)... 22, 2014 Aware, Inc. (NASDAQ: AWRE ... reported financial results for its second quarter ended June 30, ... was $6.8 million, an increase of 53% compared to $4.4 ... patent related income in the second quarter of 2014 was ... of 2013. The increase in revenue and operating income was ...
(Date:7/22/2014)... thawing might not be good for the average steak, ... as they prepare to survive Alaska,s winter cold. , ... outside than a steak does in your freezer and ... in better shape than the steak," said Don Larson, ... on a recent paper demonstrating that freeze tolerance in ...
(Date:7/22/2014)... international collaboration known as the ,1000 Bull Genomes Project, ... and dairy cattle while also improving animal health and ... on sequencing the whole genomes of 234 individual bulls ... -- are reported in the journal Nature Genetics ... use this information to reduce or eliminate hereditary diseases ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2014 Financial Results 2Aware, Inc. Reports Second Quarter 2014 Financial Results 3Aware, Inc. Reports Second Quarter 2014 Financial Results 4Aware, Inc. Reports Second Quarter 2014 Financial Results 5Aware, Inc. Reports Second Quarter 2014 Financial Results 6Aware, Inc. Reports Second Quarter 2014 Financial Results 7Alaska frogs reach record lows in extreme temperature survival 2Alaska frogs reach record lows in extreme temperature survival 3Whole-genome sequencing of bulls in key beef and dairy breeds 2
... August 16, 2011 The world,s top scientists and ... their latest research findings at the 12th International Congress of ... Society of Human Genetics (ASHG), which will be held on ... Convention Center. Founded in 1948, the American Society ...
... on the total dosage of zinc and the composition of ... episodes by up to 40%, says Dr. Harri Hemila from ... zinc lozenges are dissolved slowly in the mouth. Interest ... serendipitous observation that a cold of a young girl with ...
... The U.S. Departments of Energy and Agriculture have awarded ... improving the efficiency and cost-effectiveness of growing biofuel and ... effort by the Obama administration to develop domestic renewable ... for America,s energy needs and creating new opportunities for ...
Cached Biology News:American Society of Human Genetics to host 12th International Congress of Human Genetics 2American Society of Human Genetics to host 12th International Congress of Human Genetics 3USDA and DOE fund 10 research projects to accelerate bioenergy crop production 2
SlowFade Antifade Kit with DAPI...
Vitellogenin (Japanese medaka) Standard...
nuclear RNA export factor 1, mRNA...
... SAGE (serial analysis of gene ... expression analysis. Expression profiles generated ... to detect low-abundance transcripts making ... genes. The I-SAGE Kit is ...
Biology Products: